These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9702926)

  • 41. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
    Mayet J; Ariff B; Wasan B; Chapman N; Shahi M; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 2000 Nov; 36(5):755-9. PubMed ID: 11082139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy.
    Liebson PR; Serry RD
    Curr Hypertens Rep; 2000 Jun; 2(3):260-70. PubMed ID: 10981159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND LONG-TERM THERAPY WITH LOSARTAN].
    Dotsenko SY; Tokarenko AA; Tokarenko II
    Lik Sprava; 2015; (7-8):17-21. PubMed ID: 27491145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.
    Verdecchia P; Angeli F; Gattobigio R; Sardone M; Pede S; Reboldi GP
    Am J Hypertens; 2006 May; 19(5):493-9. PubMed ID: 16647622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of long-term uncontrolled antihypertensive therapy on the echocardiographic signs of left-heart hypertrophy in patients with mild and moderate arterial hypertension].
    Lerman OV; Metelitsa VI; Filatova NP; Duda SG; Malysheva NV; Vygodin VA
    Ter Arkh; 1997; 69(1):43-6. PubMed ID: 9163049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regression of left ventricular hypertrophy.
    Liebson PR; Grandits G; Grimm RH
    JAMA; 1996 Aug; 276(7):526-7. PubMed ID: 8709396
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [EFFICACY OF STANDARD TWO-YEAR COMPREHENSIVE THERAPY TO ACHIEVE TARGET BLOOD PRESSURE AND REGRESSION DEGREES OF REMODELING OF THE LEFT VENTRICULAR HYPERTROPHY IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION WITH COMORBID HYPERTENSION].
    Denesiuk EV
    Lik Sprava; 2015; (7-8):22-9. PubMed ID: 27491146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic advances in the treatment of left ventricular hypertrophy.
    Natsume T
    Eur Heart J; 1993 Jul; 14 Suppl D():33-7. PubMed ID: 8370375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complete reversal of hypertensive cardiomyopathy after initiating combined antihypertensive therapy.
    Holl MJ; van de Poll SW; Michels M
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27060071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.
    Schussheim AE; Diamond JA; Phillips RA
    Am J Cardiol; 2001 Jan; 87(1):61-5. PubMed ID: 11137835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?
    Cuspidi C; Esposito A; Negri F; Sala C; Masaidi M; Giudici V; Zanchetti A; Mancia G
    Am J Hypertens; 2008 Apr; 21(4):458-63. PubMed ID: 18369363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.
    Assadi F
    Pediatr Cardiol; 2007; 28(1):27-33. PubMed ID: 17308944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
    Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B;
    Ann Intern Med; 2007 Sep; 147(5):311-9. PubMed ID: 17785486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.